Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

AMRUTANJAN HEALTH CARE LTD.

NSE : AMRUTANJANBSE : 590006ISIN CODE : INE098F01031Industry : Pharmaceuticals & DrugsHouse : Amrutanjan

BSE769.3037.85 (+5.17 %)

PREV CLOSE ( ) 731.45

OPEN PRICE ( ) 737.30

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 5833

TODAY'S LOW / HIGH ( )732.60 777.00

52 WK LOW / HIGH ( )548.05 835.45

NSE768.3536.45 (+4.98 %)

PREV CLOSE( ) 731.90

OPEN PRICE ( ) 727.00

BID PRICE (QTY) 768.35 (38)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 88010

TODAY'S LOW / HIGH( ) 725.15 776.00

52 WK LOW / HIGH ( )544.1 842.9

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 09-09 1936

Management Info

S Sambhu Prasad - Chairman S Sambhu Prasad - Managing Director

Registered Office

Address New 103 (Old 42-45),Luz Church Road,Mylapore,
Chennai,
Tamil Nadu-600004

Phone 044-24994164 / 24994146 / 24994465 / 24994366 / 24669000

Email customercare@amrutanjan.com

Website www.amrutanjan.com

Registrars Details

Cameo Corporate Services Ltd

Subramanian Buildings No 1 ,Club House Road,,Chennai

Listing : BSE, NSE

NEWS

07Jul Amrutanjan Health Care informs about R
Amrutanjan Health Care has informed that it enclosed the certificate iss..

07Apr Amrutanjan Health Care informs about c
Pursuant to Regulation 74 (5) of the SEBI (Depository Participants) Regu..

17Jul Amrutanjan Health Care informs about l
Amrutanjan Health Care has informed that the Company has received a requ..

08Jul Amrutanjan Health Care informs about c
Pursuant to Regulation 74 (5) of the SEBI (Depository Participants) Regu..

25Jun Amrutanjan Health Care informs about t
Amrutanjan Health Care has informed that the trading window for dealing..

Financials

Rs. in Millions

	QTR Jun 25	ANNUAL 25
Net Profit	83.1000000000001	508.36
Gross Profit	112.92	691.35
Operating Profit	128.75	758.8
Net Sales	940.46	4518.16

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Glenmark Pharma (BSE) 2053.50 (3.16%)	M.Cap ( in Cr)57949.94
Acutaas Chemicals (BSE) 1475.10 (3.49%)	M.Cap ( in Cr)12076.48
Coral Laboratories (BSE) 520.90 (8.30%)	M.Cap ( in Cr)186.10
Blue Jet Healthcare (BSE) 744.20 (4.99%)	M.Cap ( in Cr)12909.30
Alkem Laboratories (BSE) 5336.45 (0.61%)	M.Cap ( in Cr)63805.26

Shareholding Pattern

	PROMOTERS	46.52%
	NON-INSTITUTION	38.37%
	MUTUAL FUNDS/UTI	7.55%
	FI/BANKS/INSURANCE	0.09%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
ICICI Pru FMCG Fund(G)	2.51
DSP Small Cap Fund-Reg(G)	0.62

Risk Disclosures on Derivatives

Smart Quotes

AMRUTANJAN HEALTH CARE LTD.